Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing

Ceritinib (CER) is a potent drug that has been recently approved by the Food and Drug Administration for the treatment of patients with non-small cell lung cancer harboring the anaplastic lymphoma kinase mutation gene. The existing methods for the quality control of CER are very limited and suffer f...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuhejail, Reem M., Alzoman, Nourah Z., Darwish, Ibrahim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609451/
https://www.ncbi.nlm.nih.gov/pubmed/37894533
http://dx.doi.org/10.3390/molecules28207054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609451/
https://www.ncbi.nlm.nih.gov/pubmed/37894533
http://dx.doi.org/10.3390/molecules28207054

Ejemplares similares